We evaluated the efficacy of BTYNB in vitro and found that the typical malignant phenotypes of ESCC cell lines with high IGF2BP1 expression were sharply repressed, and the IGF2BP1-INHBA interaction was disturbed by BTYNB. Here, IGF2BP1 is linked to esophageal squamous cell carcinoma.